News Results for Immunodiagnostic Systems Holdings (IDH)

  • 21 Feb
    17:20
    Director Deals - Immunodiagnostic Systems Holdings PLC (IDH)

    Peter Williamson, Non Executive Director, bought 5,000 shares in the company on the 21st February 2020 at a price of 224.00p. The Director now holds 45,000 shares. Story provided by...

  • 21 Feb
    10:25
    Director Deals - Immunodiagnostic Systems Holdings PLC (IDH)

    Paul Martin, Financial Director, bought 3,000 shares in the company on the 20th February 2020 at a price of 220.00p. The Director now holds 22,350 shares. NOTE: Average price Story provided by...

  • 20 Feb
    17:00
    Director Deals - Immunodiagnostic Systems Holdings PLC (IDH)

    Jaap Stuut, Chief Executive Officer, bought 2,500 shares in the company on the 20th February 2020 at a price of 210.00p. The Director now holds 7,500 shares. Story provided by...

  • 19 Jun
    15:00
    Immunodiagnostic Systems posts modest profit as margins shrink

    Immunodiagnostic Systems Holdings posted a modest annual profit after rising sales were offset by higher R&D and administrative spending. Pre-tax profit for the year through March rose to...

  • 07 Jan
    10:40
    Director Deals - Immunodiagnostic Systems Holdings PLC (IDH)

    Klaus Kaspar, Non Executive Director, bought 3,000 shares in the company on the 4th January 2019 at a price of 188.00p. The Director now holds 18,100 shares. Story provided by...

  • 18 Dec
    16:30
    Director Deals - Immunodiagnostic Systems Holdings PLC (IDH)

    Peter Williamson, Non Executive Director, bought 10,000 shares in the company on the 18th December 2018 at a price of 187.00p. The Director now holds 40,000 shares. Story provided by...

  • 06 Dec
    17:20
    Director Deals - Immunodiagnostic Systems Holdings PLC (IDH)

    Jaap Stuut, Chief Executive Officer, bought 2,500 shares in the company on the 6th December 2018 at a price of 190.00p. The Director now holds 5,000 shares. Story provided by StockMarketWire.com...

  • 06 Dec
    16:30
    Director Deals - Immunodiagnostic Systems Holdings PLC (IDH)

    Paul Martin, Financial Director, bought 2,250 shares in the company on the 6th December 2018 at a price of 184.00p. The Director now holds 19,350 shares. Story provided by StockMarketWire.com...

  • 30 Aug
    09:24
    Immunodiagnostic Systems expands share buyback programme

    Diagnostic testing kits producer Immunodiagnostic Systems Holdings caved into shareholder pressure Thursday as it announced plans to expand its buyback programme and acquire a further 1m shares....

  • 21 Mar
    13:15
    Director Deals - Immunodiagnostic Systems Holdings PLC (IDH)

    Paul Martin, Financial Director, bought 2,000 shares in the company on the 21st March 2018 at a price of 228.00p. The Director now holds 17,100 shares. Story provided by StockMarketWire.com...

  • 16 Jan
    08:24
    IDS partnership agreement with Technogenetics

    Immunodiagnostic Systems Holdings has reached agreement with Technogenetics srl to enable IDS to sell TGS's range of assay kits under the IDS brand, on a global basis. TGS produces a broad range...

  • 23 Oct
    08:28
    IDH first half revenues fall

    Immunodiagnostic Systems Holdings' first half revenues are 4% down on last year due to a fall in antibody licence income from a large customer which had been expected. It said that unaudited...

  • 10 Aug
    14:13
    Immunodiagnostic Systems launches IDS-iSYS

    Immunodiagnostic Systems has launched the IDS-iSYS Free Testosterone assay in the European market. The Company said it is a fully automated CLIA assay for use with serum and plasma samples on the...

  • 02 Aug
    10:45
    Director Deals - Immunodiagnostic Systems Holdings PLC (IDH)

    Regis Duval, Chief Executive Officer, bought 2,500 shares in the company on the 2nd August 2017 at a price of 305.00p. The Director now holds 46,090 shares. Story provided by StockMarketWire.com...

  • 27 Jul
    09:13
    IDS like-for-like revenues fall

    Immunodiagnostic Systems Holdings' unaudited group revenues rose to £9.7m in the first quarter, 2% higher than a year ago, shareholders at today's annual general meeting will be told. But...

  • 27 Jul
    07:08
    FLASH: IDS like-for-like revenues fall

    Story provided by StockMarketWire.com

  • 03 Jul
    16:45
    Director Deals - Immunodiagnostic Systems Holdings PLC (IDH)

    Regis Duval, Chief Executive Officer, bought 9,000 shares in the company on the 3rd July 2017 at a price of 297.00p. The Director now holds 43,590 shares. Story provided by StockMarketWire.com...

  • 28 Jun
    09:45
    Director Deals - Immunodiagnostic Systems Holdings PLC (IDH)

    Regis Duval, Chief Executive Officer, bought 5,193 shares in the company on the 28th June 2017 at a price of 295.00p. The Director now holds 34,590 shares. Story provided by StockMarketWire.com...

  • 21 Jun
    07:18
    IDS dividend up 233%

    Immunodiagnostic Systems Holdings has declared a dividend of 4.0p per share for the year to theend of March - 233% up on last time. Reported revenues increased by 4% to £40.0m. On a...

  • 21 Jun
    07:08
    FLASH: Immunodiagnostic hikes dividend

    Story provided by StockMarketWire.com

  • 21 Apr
    07:18
    IDS revenues boosted by weak pound

    Immunodiagnostic Systems Holdings expects revenue for the year ended 31 March to be approximately £40m, an increase of around 4% compared to the previous year. It said revenue had been...

  • 21 Apr
    07:02
    FLASH: IDS revenues up

    Story provided by StockMarketWire.com

  • 23 Mar
    16:05
    Director Deals - Immunodiagnostic Systems Holdings PLC (IDH)

    Paul Martin, Financial Director, bought 3,000 shares in the company on the 22nd March 2017 at a price of 277.00p. The Director now holds 13,000 shares. Story provided by StockMarketWire.com...

  • 01 Mar
    14:39
    IDH launches IDS-iSYS InaKtif MGP assay

    Immunodiagnostic Systems (IDH) has launched the IDS-iSYS InaKtif MGP assay in the European market. It says this is a fully automated CLIA assay for use with plasma samples on the IDS-iSYS...

  • 11 Jan
    17:50
    Director Deals - Immunodiagnostic Systems Holdings PLC (IDH)

    Till Campe, Non Executive Director, bought 1,500 shares in the company on the 11th January 2017 at a price of 245.00p. The Director now holds 1,790 shares. Story provided by StockMarketWire.com...

  • 21 Oct
    07:35
    IDS like-for-like revenues fall

    Immunodiagnostic Systems Holdings, a specialist producer of manual and automated diagnostic testing kits and instruments for the clinical market, expects first half revenues of £19.5m compared...

  • 21 Oct
    07:08
    FLASH: Immunodiagnostic Systems LFL revenues fall

    Story provided by StockMarketWire.com

  • 28 Jul
    08:13
    Immunodiagnostic Systems revenue down

    Immunodiagnostic Systems said it will hold its AGM today where chairman Dr Burkhard Wittek will make the following statement to shareholders. "Group revenue (unaudited) for Q1 FY2017 is £9.5m, 7%...

  • 05 Jul
    12:45
    Director Deals - Immunodiagnostic Systems Holdings PLC (IDH)

    Klaus Kaspar, Non Executive Director, bought 5,000 shares in the company on the 4th July 2016 at a price of 138.00p. The Director now holds 11,000 shares. Story provided by StockMarketWire.com...

  • 23 Jun
    16:55
    Director Deals - Immunodiagnostic Systems Holdings PLC (IDH)

    Paul Martin, Financial Director, bought 10,000 shares in the company on the 23rd June 2016 at a price of 132.00p. The Director now holds 10,000 shares. Story provided by StockMarketWire.com...

  • 22 Jun
    07:43
    IDS revenues fall

    Immunodiagnostic Systems Holding' revenue fell to £38.3m in the year to the end of March (2015: £45.4m) showed a 15.6% decline based on actual exchange rates. Excluding the acquisition of...

  • 22 Jun
    07:04
    FLASH: IDS revenues fall

    Story provided by StockMarketWire.com

  • 06 May
    10:39
    IDH launches IDS-iSYS 17-OH assay in the Europe

    Immunodiagnostic Systems has launched the IDS-iSYS 17-OH Progesterone assay in the European market. It is a fully automated assay for use with the IDS-iSYS Automated System. The launch of the...

  • 25 Apr
    07:35
    IDS revenues in line with guidance

    Immunodiagnostic Systems Holdings expects total revenues for the year ended 31 March to be around GBO39 million - down from GBP45 million last time but in line with the guidance given in...

  • 25 Apr
    07:05
    FLASH: IDS revenues fall

    Story provided by StockMarketWire.com

  • 04 Jan
    07:50
    IDS finance director takes up reins

    Immunodiagnostic Systems Holdings has announced that Paul Martin has officially joined the board of IDS and taken up his position as group finance director. Story provided by StockMarketWire.com

  • 18 Dec
    09:48
    IDS launches salivary cortisol assay

    Immunodiagnostic Systems Holdings has launched the IDS-iSYS salivary cortisol assay in the European market - a fully automated assay for use with the IDS-iSYS Automated System. The launch of the...

  • 24 Nov
    17:08
    FTSE falls on travel stocks as retail issues fade

    FTSE indices closed lower, having been dragged down all day by falls among travel-related stocks as traders revealed their caution over on-going violence and political tensions in the Middle East....

  • 24 Nov
    12:02
    FTSE falls on travel, mixed bag as Europe falters

    FTSE indices continued to track lower to midday with travel-related stocks, such as airlines, hurting on global security fears, and tightening tensions in the Middle East as Turkish fighters downed...

  • 24 Nov
    09:04
    IDS' revenues

    Immunodiagnostic Systems Holdings' first half revenues fell to £19.4m - down from £22.1m last time but in line with its trading update on 13 October. Automated revenues (IDS-iSYS) totalled...

  • 24 Nov
    08:59
    FTSE indices follow broader retail sector south

    FTSE indices resumed their southerly bent early on with travel-related stocks taking a dive, and a mixed bag of supermarkets, high-street retail, consumer goods outfits and financials providing...

  • 24 Nov
    07:05
    FLASH: IDS revenues fall

    Story provided by StockMarketWire.com

  • 22 Oct
    14:32
    IDS appoints chief financial officer

    Immunodiagnostic Systems Holdings has announced that Paul James Martin will join the board as chief financial officer from 4 January. Martin is a chartered accountant who started his career at...

  • 20 Oct
    14:34
    IDS strengthens its board

    Immunodiagnostic Systems Holdings - a leading solution provider to the clinical laboratory diagnostic market - has appointed Klaus Peter Kaspar as a non-executive director with effect from 1...

  • 13 Oct
    07:33
    IDS trading environment remains challenging

    Immunodiagnostic Systems Holdings expects total revenues for the six months to the end of September to be around £19m - 13% down on last time - and it warns that the near-term trading environment...

  • 13 Oct
    07:05
    FLASH: IDS revenues fall

    Story provided by StockMarketWire.com

  • 04 Aug
    14:54
    IDH resolutions passed at AGM

    Immunodiagnostic Systems Holdings has confirmed that all resolutions proposed at its annual general meeting today were passed. At 2:54pm: (LON:IDH) Immunodiagnostic Systems Holdings PLC share...

  • 04 Aug
    07:45
    IDH 'facing a lot of challenges'

    Immunodiagnostic Systems Holdings' first quarter was challenging with revenues at the group level down 15%, shareholders at the annual general meeting today will be told. Chairman Dr. Burkhard...

  • 04 Aug
    07:03
    FLASH: IDH revenues down

    Story provided by StockMarketWire.com

  • 29 Jun
    15:21
    IDS schedules AGM

    Immunodiagnostic Systems Holdings will hold its annual general meeting at its registered office at 10 Didcot Way, Boldon Business Park, Boldon, Tyne & Wear NE35 9PD, on 4 August at 2 p.m. At...

  • 29 Jun
    09:57
    IDS chief financial officer leaves

    Immunodiagnostic Systems Holdings has confirmed that chief financial officer Chris Yates, who resigned on 4 December, is leaving the group today following the end of his notice period. The board...

  • 23 Jun
    07:49
    IDS revenues fall

    Immunodiagnostic Systems Holdings - a leading producer of manual and automated specialist diagnostic testing kits - posts pre-tax profits of £4.05m for the year to the end of March, down from...

  • 23 Jun
    07:11
    FLASH: IDS revenues fall

    Story provided by StockMarketWire.com

  • 10 Jun
    08:03
    IDS strengthens its board

    Immunodiagnostic Systems Holdings has appointed Peter Williamson as a non-executive director with effect from 15 June. Williamson holds a Master of Business Administration from the University of...

  • 29 May
    08:58
    FTSE makes flaccid gains on resources, pharmas

    FTSE indices were a jot firmer ahead of US GDP data this afternoon, with resources, pharma and retail stocks providing flaccid cue in a session flush with minnow news. Asian markets were up but...

  • 29 May
    07:53
    IDS in line with guidance

    Immunodiagnostic Systems Holdings' revenues for the year that ended on 31 March revenues are expected to be £45m in line with the guidance reconfirmed in April. The board expects revenues for...

  • 29 May
    07:10
    FLASH: IDS in line with guidance

    Story provided by StockMarketWire.com

  • 21 Apr
    07:40
    IDH revenues down

    Immunodiagnostic Systems Holdings, a leading solution provider to the clinical laboratory diagnostic market, expects revenues for the year ended 31 March to be around £45m - down from £52m in...

  • 21 Apr
    07:06
    FLASH: IDH in line with guidance

    Story provided by StockMarketWire.com

  • 02 Apr
    09:43
    IDS chief executive takes up reins

    Immunodiagnostic Systems Holdings has confirmed that Patricio Lacalle has officially taken up his position as chief executive and that Burkhard Wittek will revert to being non-executive chairman...

  • 03 Feb
    09:01
    IDS appoints chief executive

    Immunodiagnostic Systems Holdings, a leading producer of manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets, has appointed Patricio...

  • 24 Dec
    15:27
    CEO of Immunodiagnostic Systems to leave in early January

    Immunodiagnostic Systems Holdings has announced that Patrik Dahlen, its chief executive officer, will leave on January 4. Last month it said that Mr Dahlen had given 12 months' notice to leave the...

  • 18 Dec
    10:30
    Director Deals - Immunodiagnostic Systems Holdings PLC (IDH)

    Chris Yates, Financial Director, sold 5,000 shares in the company on the 16th December 2014 at a price of 320.00p. The Director now holds 500 shares representing 0.00% of the shares in issue....

  • 12 Dec
    08:39
    IDS launches 1,25-Dihydroxy Vitamin D assay

    Immunodiagnostic Systems Holdings, a leading solution provider to the clinical laboratory diagnostic market, has received European CE Mark declaration for the IDS-iSYS 1,25 VitDXp assay - a fully...

  • 12 Dec
    07:14
    FLASH: IDS launches 1,25-Dihydroxy Vitamin D assay

    Story provided by StockMarketWire.com

  • 04 Dec
    16:55
    Director Deals - Immunodiagnostic Systems Holdings PLC (IDH)

    Patrik Dahlen, Chief Executive Officer, sold 44,751 shares in the company on the 3rd December 2014 at a price of 323.00p. NOTE: Sold on 2nd & 3rd Dec 2014. Story provided by...

  • 25 Nov
    14:02
    IDS revenues fall

    Immunodiagnostic Systems Holdings' first half group revenues fell to £22.1m in the six months to the end of September - down from £26.9m a year ago. Adjusted EBIT was £3.2m (H1 2014: £5.2m)...

  • 25 Nov
    13:43
    IDH downgraded by N+1

    Brokerage firm N+1 Singer has added specialty diagnostic group Immunodiagnostic Systems Holdings (LON:IDH) to its list of stocks to steer clear of and moved to an outright 'sell' investment rating...

  • 25 Nov
    07:36
    IDS chief executive to step down

    Immunodiagnostic Systems Holdings chief executive Patrik Dahlen has given notice of his resignation from the company for professional reasons. Dahlen will remain in post for a period of up to one...

  • 14 Oct
    13:13
    IDH sees fall in first half revenues

    Immunodiagnostic Systems Holdings says first half revenues will be around £22m - down from £27m last time. Automated revenues declined by around 9% compared to the prior year period due to a...

  • 14 Oct
    13:02
    IDH upgraded by N+1

    N+1 Singer has upgraded its recommendation on Immunodiagnostic Systems (LON:IDH) to ‘hold’ from ‘sell’, following today’s first half trading update. While the broker stated that the...

  • 15 Sep
    17:05
    FTSE down as SABMiller gains fail to offset fallers

    The FTSE closed a jot down amid a surge of interim results, led lower by financial and resources stocks. SABMiller's (SAB) gains after its rejected tilt at Heineken were in focus, while Scotland's...

  • 15 Sep
    07:56
    IDS downbeat

    Immunodiagnostic Systems Holdings has warned that revenues for the year ending 31 March 2015 will be below current expectations and in the range of £45m - £47m. This includes an anticipated...

  • 15 Sep
    07:11
    FLASH: IDS revenues to be below forecasts

    Story provided by StockMarketWire.com

  • 10 Sep
    07:47
    IDS takes over Diametra

    Immunodiagnostic Systems Holdings has acquired Diametra, an Italian company specialised in the development and commercialisation of manual immunoenzymatic assays. Diametra is based in Spello,...

  • 10 Sep
    07:04
    FLASH: IDS takes over Diametra

    Story provided by StockMarketWire.com

  • 21 Aug
    11:47
    Immunodiagnostic Systems upgraded by N+1

    Equity research analysts at N+1 Singer have upgraded their recommendation on Immunodiagnostic Systems (LON:IDH) to ‘hold’ from ‘sell’ after the company received approval from the China Food...

  • 21 Aug
    09:48
    IDS-iSYS gets clearance from China FDA

    Immunodiagnostic Systems Holdings has received notice that the China Food and Drug Administration has approved the company's IDS-iSYS automated immunoassay instrument for sale in the Chinese...

  • 04 Aug
    09:39
    Immunodiagnostic Systems downgraded by N+1

    N+1 Singer has downgraded its recommendation on Immunodiagnostic Systems (LON:IDH) to ‘sell’ from ‘hold’ following today’s AGM statement, which highlighted performance in line with...

  • 04 Aug
    08:06
    Immunodiagnostic makes satisfactory start

    Immunodiagnostic Systems Holdings has made a satisfactory start to its financial year, shareholders at the annual general meeting laster today will be told. Chairman Dr. Anthony Martin will say:...

  • 04 Aug
    07:09
    FLASH: Immunodiagnostic makes satisfactory start

    Story provided by StockMarketWire.com

  • 24 Jun
    08:03
    IDS sees return to top line growth

    Immunodiagnostic Systems Holdings return to top line growth in the year to the end of March with revenues up 5.0% at £52.3m. The group said automated revenues (IDS-iSYS) now account for 42.8% of...

  • 24 Jun
    07:10
    FLASH: IDS sees return to top line growth

    Story provided by StockMarketWire.com

  • 15 Apr
    07:47
    IDS revenues up

    Immunodiagnostic Systems Holdings expects results for the year ended 31 March to be in line with the board's forecasts and the guidance given at the time of the interim results announcement in...

  • 15 Apr
    07:09
    FLASH: IDS in line with forecasts

    Story provided by StockMarketWire.com

  • 07 Mar
    08:08
    IDS non-exec steps down

    Immunodiagnostic Systems Holdings non-executive director Dr Burkhard Wittek has stepped down from the board. Chairman Dr Anthony Martin said: "On behalf of the Board I would like to thank Dr....

  • 27 Nov
    09:41
    IDS adjusted pre-tax profits rise

    First half revenues at Immunodiagnostic Systems Holdings rose by 13% to £26.9m in the six months to the end of September. IDS - a leading producer of automated and manual specialist diagnostic...

  • 10 Oct
    07:48
    IDS in line with forecasts

    Immunodiagnostic Systems has confirmed that it expects results for the six months to the end of September to be in line with the board's forecasts. Total revenues are expected to be around £27m...

  • 10 Oct
    07:12
    FLASH: IDS in line with forecasts

    Story provided by StockMarketWire.com

  • 26 Jul
    15:14
    IDS resolutions passed at AGM

    Immunodiagnostic Systems Holdings has confirmed that all resolutions proposed at its annual general meeting earlier today (26 July) were passed. At 3:14pm: (LON:IDH) Immunodiagnostic Systems...

  • 26 Jul
    12:03
    Immunodiagnostic Systems' year starts encouragingly

    Immunodiagnostic Systems Holdings said it has made an encouraging start to this financial year with financial performance in line with management expectations. "We believe that the strategy we...

  • 02 Jul
    11:35
    Director Deals - Immunodiagnostic Systems Holdings PLC (IDH)

    Chris Yates, Financial Director, bought 500 shares in the company on the 1st July 2013 at a price of 459.00p. The Director now holds 5,500 shares. Story provided by StockMarketWire.com Director...

  • 02 Jul
    11:35
    Director Deals - Immunodiagnostic Systems Holdings PLC (IDH)

    Patrik Dahlen, Chief Executive Officer, bought 5,719 shares in the company on the 1st July 2013 at a price of 450.00p. The Director now holds 44,751 shares. Story provided by StockMarketWire.com...

  • 24 Jun
    07:14
    FLASH: IDS gets FDA clearance for Vitamin D test

    Story provided by StockMarketWire.com

  • 17 Jun
    07:18
    Immunodiagnostic Systems hits target

    Diagnostic testing kits specialist Immunodiagnostic Systems reported revenue of £49.8m for the year to end-March (2012: £53.7m), in line with management expectations. Automated revenues...

  • 17 Jun
    07:10
    FLASH: IDS adjusted pre-tax profits down 21%

    Story provided by StockMarketWire.com

  • 02 May
    09:36
    IDS enters into Chinese diagnostics market

    Immunodiagnostic Systems Holdings has appointed Beijing Leadman Biochemistry Technology as exclusive distributor for the IDS-iSYS instrument and assays in China. In addition, IDS and Leadman...

  • 02 May
    07:44
    FLASH: IDS enters into Chinese diagnostics market

    Story provided by StockMarketWire.com

  • 10 Apr
    08:35
    IDS in line with its expectations

    Immunodiagnostic Systems Holdings expects results for the full year to the end of March to be in line with the board's forecasts set out at the interim results in November. Total revenues are...

  • 10 Apr
    07:23
    FLASH: IDS in line with its expectations

    Story provided by StockMarketWire.com

Shares Magazine

Shares Magazine

Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.

Don't miss the latest news! Sign up today

Investor Events

Investor Events

Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.

Terms & Conditions | Privacy Policy | Cookies